0001540171-20-000002.txt : 20200508 0001540171-20-000002.hdr.sgml : 20200508 20200507180248 ACCESSION NUMBER: 0001540171-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200508 DATE AS OF CHANGE: 20200507 EFFECTIVENESS DATE: 20200508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avalyn Pharma Inc. CENTRAL INDEX KEY: 0001540171 IRS NUMBER: 452463191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-366535 FILM NUMBER: 20857997 BUSINESS ADDRESS: STREET 1: 701 PIKE STREET STREET 2: SUITE 1500 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: (206) 707-0340 MAIL ADDRESS: STREET 1: 701 PIKE STREET STREET 2: SUITE 1500 CITY: SEATTLE STATE: WA ZIP: 98101 FORMER COMPANY: FORMER CONFORMED NAME: Genoa Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120120 D 1 primary_doc.xml X0708 D LIVE 0001540171 Avalyn Pharma Inc. 701 PIKE STREET SUITE 1500 SEATTLE WA WASHINGTON 98101 (206) 707-0340 DELAWARE Genoa Pharmaceuticals, Inc. Corporation true A. Bruce Montgomery c/o Avalyn Pharma Inc. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Executive Officer Director Tiba Aynechi c/o Avalyn Pharma Inc. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Sofia Ioannidou c/o Avalyn Pharma Inc. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Jonathan Leff c/o Avalyn Pharma Inc. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Niall O'Donnell c/o Avalyn Pharma Inc. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Ketan Patel c/o Avalyn Pharma Inc. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Robert Mittendorff c/o Avalyn Pharma Inc. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Heather Preston c/o Avalyn Pharma Inc. 701 Pike Street, Suite 1500 Seattle WA WASHINGTON 98101 Director Biotechnology Decline to Disclose 06b false 2020-04-24 false true false 0 35695957 35499998 195959 false 8 0 0 0 false Avalyn Pharma Inc. /s/ Nancy McKinley Nancy McKinley VP, Finance 2020-05-07